Rigel Pharmaceuticals
RIGL
#6815
Rank
C$1.05 B
Marketcap
C$55.90
Share price
-13.26%
Change (1 day)
15.31%
Change (1 year)

EPS for Rigel Pharmaceuticals (RIGL)

EPS in 2023 (TTM): C-$0.30

According to Rigel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C$24.91. In 2022 the company made an earnings per share (EPS) of C-$0.48 a decrease over its 2021 EPS that were of C-$0.14.

EPS history for Rigel Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C-$0.30-37.59%
2022C-$0.48240%
2021C-$0.14-37.5%
2020C-$0.23-60%
2019C-$0.56-11.11%
2018C-$0.63-26.23%
2017C-$0.86-17.57%
2016C-$1.0425.42%
2015C-$0.83-42.72%
2014C-$1.451.98%
2013C-$1.42-24.06%
2012C-$1.88-4.32%
2011C-$1.96-290.41%
2010C$1.03-126.64%
2009C-$3.86-25.14%
2008C-$5.1641.86%
2007C-$3.6470.86%
2006C-$2.13-27.4%
2005C-$2.93-33.33%
2004C-$4.40-37.73%
2003C-$7.06-31.83%
2002C-$10.36-63.55%
2001C-$28.43-96.43%
2000C-$797.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
C$22.87-8.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$9.42-62.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
C-$0.54-102.15%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
C-$2.66-110.70%๐Ÿ‡บ๐Ÿ‡ธ USA